Published in Acta Otorhinolaryngol Ital on August 01, 2012
The changing face of complicated infantile hemangioma treatment. Pediatr Radiol (2016) 1.00
Beta blockers: an innovation in the treatment of infantile hemangiomas. J Clin Aesthet Dermatol (2014) 0.80
Analysis of the therapeutic evolution in the management of airway infantile hemangioma. World J Clin Pediatr (2016) 0.77
Propranolol in use for treatment of complex infant hemangiomas: literature review regarding current guidelines for preassessment and standards of care before initiation of therapy. ScientificWorldJournal (2013) 0.75
Propranolol for severe hemangiomas of infancy. N Engl J Med (2008) 11.32
Clinical guidelines: developing guidelines. BMJ (1999) 6.01
Propranolol treatment for hemangioma of infancy: risks and recommendations. Pediatr Dermatol (2009) 3.50
GLUT1: a newly discovered immunohistochemical marker for juvenile hemangiomas. Hum Pathol (2000) 2.86
Propranolol for severe infantile hemangiomas: follow-up report. Pediatrics (2009) 2.76
Management of alarming hemangiomas in infancy: a review of 25 cases. Pediatrics (1990) 2.20
Clonality and altered behavior of endothelial cells from hemangiomas. J Clin Invest (2001) 2.20
Multipotential stem cells recapitulate human infantile hemangioma in immunodeficient mice. J Clin Invest (2008) 2.10
Prospective study of infantile hemangiomas: demographic, prenatal, and perinatal characteristics. J Pediatr (2007) 1.96
Infantile hemangiomas: current knowledge, future directions. Proceedings of a research workshop on infantile hemangiomas, April 7-9, 2005, Bethesda, Maryland, USA. Pediatr Dermatol (2005) 1.77
Propranolol for complicated infantile haemangiomas: a case series of 30 infants. Br J Dermatol (2010) 1.76
Propranolol therapy for infantile haemangiomas: review of the literature. Int J Pediatr Otorhinolaryngol (2010) 1.72
Pharmacologic therapies for infantile hemangioma: is there a rational basis? Plast Reconstr Surg (2011) 1.54
Propranolol as first-line treatment for rapidly proliferating infantile haemangiomas. J Plast Reconstr Aesthet Surg (2010) 1.50
Oral corticosteroid use is effective for cutaneous hemangiomas: an evidence-based evaluation. Arch Dermatol (2001) 1.44
Two infants with life-threatening diffuse neonatal hemangiomatosis treated with cyclophosphamide. Pediatr Blood Cancer (2006) 1.41
Update on hemangiomas and vascular malformations of the head and neck. Eur Arch Otorhinolaryngol (2008) 1.39
Hypoglycemia in children taking propranolol for the treatment of infantile hemangioma. Arch Dermatol (2010) 1.38
Role of Propranolol in the therapeutic strategy of infantile laryngotracheal hemangioma. Int J Pediatr Otorhinolaryngol (2009) 1.36
Propranolol for airway hemangiomas: case report of novel treatment. Laryngoscope (2009) 1.35
Classification and management of the various superficial vascular anomalies: hemangiomas and vascular malformations. J Dermatol (1997) 1.35
Management of congenital subglottic hemangioma: trends and success over the past 17 years. Otolaryngol Head Neck Surg (2005) 1.23
Propranolol for infantile hemangiomas: early experience at a tertiary vascular anomalies center. Laryngoscope (2010) 1.21
The biology and management of subglottic hemangioma: past, present, future. Laryngoscope (2004) 1.20
Hyperkalemia complicating propranolol treatment of an infantile hemangioma. Pediatrics (2010) 1.17
Propranolol for the treatment of airway hemangiomas: a case series and treatment algorithm. Int J Pediatr Otorhinolaryngol (2010) 1.14
Infantile hemangiomas: an emerging health issue linked to an increased rate of low birth weight infants. J Pediatr (2008) 1.08
Propranolol in the therapeutic strategy of infantile laryngotracheal hemangioma: A preliminary retrospective study of French experience. Int J Pediatr Otorhinolaryngol (2010) 1.06
Are 1-2 tablets dangerous? Beta-blocker exposure in toddlers. J Emerg Med (2004) 1.03
Successful treatment of isolated subglottic haemangioma with propranolol alone. Int J Pediatr Otorhinolaryngol (2009) 1.02
Expression of components of the renin-angiotensin system in proliferating infantile haemangioma may account for the propranolol-induced accelerated involution. J Plast Reconstr Aesthet Surg (2010) 0.98
Life-threatening infantile haemangioma: a dramatic response to propranolol. J Eur Acad Dermatol Venereol (2009) 0.96
[Efficacy of beta-blockers in infantile capillary haemangiomas: the physiopathological significance and therapeutic consequences]. Ann Dermatol Venereol (2008) 0.95
Propranolol in the management of airway infantile hemangiomas. Arch Otolaryngol Head Neck Surg (2010) 0.94
Current knowledge of the pathogenesis of infantile hemangiomas. Arch Facial Plast Surg (2005) 0.92
Emerging concepts in airway infantile hemangioma assessment and management. Otolaryngol Head Neck Surg (2009) 0.90
Pediatric head and neck lesions. Pediatr Clin North Am (1998) 0.89
Propranolol for the treatment of a life-threatening subglottic and mediastinal infantile hemangioma. J Pediatr (2010) 0.88
Severe hypoglycemia during successful treatment of diffuse hemangiomatosis with propranolol. Pediatr Dermatol (2010) 0.88
Subglottic hemangioma. Otolaryngol Clin North Am (2008) 0.88
Initial experience using propranolol as the sole treatment for infantile airway hemangiomas. Int J Pediatr Otorhinolaryngol (2010) 0.87
Management of infantile subglottic hemangioma: acebutolol or propranolol? Int J Pediatr Otorhinolaryngol (2010) 0.87
Diffuse neonatal hemangiomatosis treatment with cyclophosphamide: a case report. J Pediatr Hematol Oncol (2009) 0.82
Management of subglottic hemangioma. Curr Opin Otolaryngol Head Neck Surg (2004) 0.82
Optimal treatment of vascular birthmarks. Am J Clin Dermatol (2003) 0.81
Subglottic hemangioma as a cause of respiratory obstruction in infants. Ann Otol Rhinol Laryngol (1961) 0.80
Use of propranolol to treat multicentric airway haemangioma. J Laryngol Otol (2010) 0.79
Case report: Treatment failure using propanolol for treatment of focal subglottic hemangioma. Int J Pediatr Otorhinolaryngol (2010) 0.79
Propranolol treatment for subglottic haemangioma. Arch Dis Child Fetal Neonatal Ed (2011) 0.78
A review of the current management of infantile subglottic haemangioma, including a comparison of CO(2) laser therapy versus tracheostomy. Int J Pediatr Otorhinolaryngol (2002) 0.77
Management of subglottic haemangioma. J Laryngol Otol (1998) 0.76
[Clinical observations on propranolol use for paediatric airway hemangiomas]. Acta Otorrinolaringol Esp (2010) 0.76
Clinical-pathological correlates of congenital subglottic hemangiomas. Ann Otol Rhinol Laryngol Suppl (1983) 0.76
Impact of facial paralysis on patients with acoustic neuroma. Laryngoscope (2000) 1.51
Determinants of speech perception in children after cochlear implantation. Lancet (2000) 1.18
Reliability of a rating scale for measuring speech intelligibility after pediatric cochlear implantation. Otol Neurotol (2001) 1.14
Speech intelligibility in children after cochlear implantation. Am J Otol (1998) 1.13
Variations in gains in auditory performance from pediatric cochlear implantation. Otol Neurotol (2002) 1.11
Deaf children with cochlear implants before the age of 1 year: comparison of preverbal communication with normally hearing children. Int J Pediatr Otorhinolaryngol (2007) 1.04
One touch non-PC-based digital recording during otolaryngological endoscopic examination. Clin Otolaryngol (2011) 0.93
Laryngeal tuberculosis at the end of the 20th century. J Laryngol Otol (1997) 0.91
Newborn hearing screening: effectiveness, importance of high-risk factors, and characteristics of infants in the neonatal intensive care unit and well-baby nursery. Otol Neurotol (2005) 0.91
Laryngeal cancer: smoking is not the only risk factor. B-ENT (2012) 0.89
Cochlear implants in young children: the relationship between speech perception and speech intelligibility. Ear Hear (1999) 0.88
Is there a correlation between vascular loops and unilateral auditory symptoms? Laryngoscope (1998) 0.88
Submasseteric abscess. J Laryngol Otol (2001) 0.87
Meniere's disease: Still a mystery disease with difficult differential diagnosis. Ann Indian Acad Neurol (2011) 0.85
Cochlear implantation in children with large vestibular aqueduct syndrome and a review of the syndrome. Int J Pediatr Otorhinolaryngol (2001) 0.85
Educational placement of deaf children following cochlear implantation. Br J Audiol (1998) 0.84
Approach to communication, speech perception and intelligibility after paediatric cochlear implantation. Br J Audiol (2000) 0.84
Hearing evaluation with distortion-product otoacoustic emissions in young patients undergoing haemodialysis. Clin Otolaryngol Allied Sci (2001) 0.82
Laryngeal pemphigus without skin manifestations and review of the literature. Eur Arch Otorhinolaryngol (2006) 0.81
Impairments, disabilities, and handicaps after acoustic neuroma surgery. Clin Otolaryngol Allied Sci (2000) 0.81
Speech perception in children after cochlear implantation. Am J Otol (1998) 0.81
Indirect costs, cost-utility variations and the funding of paediatric cochlear implantation. Int J Pediatr Otorhinolaryngol (2001) 0.80
Peritonsillar abscess in children. Is incision and drainage an effective management? Int J Pediatr Otorhinolaryngol (1995) 0.79
Age at implantation and development of vocal and auditory preverbal skills in implanted deaf children. Int J Pediatr Otorhinolaryngol (2007) 0.79
Bilateral versus unilateral cochlear implantation in young children. Int J Pediatr Otorhinolaryngol (2009) 0.78
Glottic and supraglottic laryngeal cancer: epidemiology, treatment patterns and survival in 164 patients. J BUON (2013) 0.78
The use and reliability of Tait video analysis in assessing preverbal language skills in profoundly deaf and normally hearing children under 12 months of age. Int J Pediatr Otorhinolaryngol (2007) 0.78
Burkitt's lymphoma in the base of the tongue: differential diagnosis and management. ORL J Otorhinolaryngol Relat Spec (2003) 0.77
Communication development in young deaf children: review of the video analysis method. Int J Pediatr Otorhinolaryngol (2001) 0.77
Should we use ossicular remnants in ossicular reconstruction following cholesteatoma removal? ORL J Otorhinolaryngol Relat Spec (2006) 0.76
Evaluation of acoustic reflectometry in detecting otitis media in children. Br J Audiol (1993) 0.76
Topical antibiotic ear drops: are they safe? Int J Clin Pract (2006) 0.75
Use of the telephone in prelingually deaf children with a multichannel cochlear implant. Otol Neurotol (2001) 0.75
Perilymphatic fistula--the challenging enigma. Methods of intraoperative diagnosis. J Laryngol Otol (1995) 0.75
Histologic diagnosis and surgical management of primary extramedullary plasmacytoma in the middle ear cavity. Am J Otol (1996) 0.75
Concentrations of cefpodoxime in plasma, adenoid, and tonsillar tissue after repeated administrations of cefpodoxime proxetil in children. J Antimicrob Chemother (1996) 0.75
Cochlear implants: 100 pediatric case conversions from the body worn to the nucleus esprit 22 ear level speech processor. Otol Neurotol (2005) 0.75
Variation among pre-surgical CT assessments of chronic otitis media. B-ENT (2013) 0.75
Tissue detection of natural killer cells in laryngeal carcinoma. Neoplasma (2007) 0.75
Surgical correction of pinna malformations. J Plast Reconstr Aesthet Surg (2007) 0.75
Effect of subclinical lead intoxication on laryngeal cancer. Br J Clin Pract (1997) 0.75
Quantifying the bystander-effect of 2.5G mobile telephones on the speech perception of digital hearing aid users. B-ENT (2012) 0.75
Primary extramedullary plasmacytoma in the middle ear: differential diagnosis and management. J Laryngol Otol (1994) 0.75
Laryngeal paragangliomas - controversies in diagnosis and management. J BUON (2009) 0.75